Literature DB >> 7564224

Liver transplantation in nine Spanish patients with tyrosinaemia type I.

C Pérez-Cerdá1, B Merinero, P Sanz, M Castro, J Gangoiti, M J García, M Díaz, E Medina, M Ugarte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7564224     DOI： 10.1007/BF00711744

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  6 in total

1.  Liver transplantation for hereditary tyrosinemia--early transplantation following the patient's stabilization.

Authors:  E M Sokal; R Bustos; F Van Hoof; J B Otte
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

2.  Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh.

Authors:  L A Mieles; C O Esquivel; D H Van Thiel; B Koneru; L Makowka; A G Tzakis; T E Starzl
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

Review 3.  Pitfalls in the initial diagnosis of tyrosinemia: three case reports and a review of the literature.

Authors:  K J Goulden; M A Moss; D E Cole; G A Tithecott; J F Crocker
Journal:  Clin Biochem       Date:  1987-06       Impact factor: 3.281

4.  Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.

Authors:  M Tuchman; D K Freese; H L Sharp; M L Ramnaraine; N Ascher; J R Bloomer
Journal:  J Pediatr       Date:  1987-03       Impact factor: 4.406

5.  Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.

Authors:  A Salt; N D Barnes; K Rolles; R Y Calne; P T Clayton; J V Leonard
Journal:  Acta Paediatr       Date:  1992-05       Impact factor: 2.299

Review 6.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982
  6 in total
  4 in total

1.  Screening for tyrosinaemia type I.

Authors:  A C Hutchesson; S K Hall; M A Preece; A Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

2.  Nitisinone in the treatment of hereditary tyrosinaemia type 1.

Authors:  Patrick J McKiernan
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Authors:  E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

4.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.